ResearcherFirst Affiliated Hospital of Xinjiang Medical UniversityNo recent work listed

Chouman Sulidankazha

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5821-7531; OpenAlex author ID A5025381374. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p. Co-author DOI 10.1155/2023/6785005 ↗
miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7. Co-author DOI 10.1155/2022/2240605 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qilong Chen · 2 shared papers, 2022–2023 · strength 0.39
- Paper LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogen… DOI 10.1155/2023/6785005 ↗
- Paper miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7. DOI 10.1155/2022/2240605 ↗
Hai Lan Lin · 2 shared papers, 2022–2023 · strength 0.39
- Paper LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogen… DOI 10.1155/2023/6785005 ↗
- Paper miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7. DOI 10.1155/2022/2240605 ↗
Tieying He · 2 shared papers, 2022–2023 · strength 0.39
- Paper LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogen… DOI 10.1155/2023/6785005 ↗
- Paper miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7. DOI 10.1155/2022/2240605 ↗
Wei Han · 1 shared paper, 2023 · strength 0.22
- Paper LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogen… DOI 10.1155/2023/6785005 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.